Skip to main content

Moors & Cabot, Inc.

Position in AMGN — Amgen Inc

CIK 1607239 BOSTON, MA

Position in AMGN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$5,389,794
+$103,248 QoQ
Shares Held
14,884
-0.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#800
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Derivatives in AMGN

reported options exposure · as of Dec 31, 2023
CallValue
$5,460
CallShares
600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. AMGN ranks #6 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 AMGN
Amgen Inc
This page
14,884 $5,389,794

All Filings in AMGN

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,389,794 14,884
2026-03-31 $5,286,546 15,025
2025-12-31 $5,047,120 15,420
2025-09-30 $4,250,214 15,061
2025-06-30 $4,403,141 15,770
2025-03-31 $4,813,447 15,450
2024-12-31 $4,889,606 18,760
2024-09-30 $6,588,872 20,449
2024-06-30 $6,522,393 20,875
2024-03-31 $6,196,470 21,794
2023-12-31 $6,021,634 20,907
2023-12-31 $5,460 600
2023-09-30 $5,564,138 20,703
2023-06-30 $4,387,115 19,760
2023-03-31 $4,897,371 20,258
2022-12-31 $5,318,197 20,249
2022-09-30 $4,288,009 19,024
2022-06-30 $4,417,354 18,156
2022-03-31 $4,451,180 18,407
2021-12-31 $3,325,056 14,780
2021-09-30 $2,910,115 13,685
2021-06-30 $3,298,912 13,534
2021-03-31 $3,334,302 13,401
2020-12-31 $3,334,529 14,503
2020-09-30 $6,901,714 27,155
2020-06-30 $6,538,039 27,720
2020-03-31 $5,283,549 26,062